Black Rock Inc. Intellia Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,109,268 shares of NTLA stock, worth $204 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,109,268

Previous 9,010,695 1.09%

Holding current value

$204 Million

Previous $275 Million 8.79%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$23.82 - $32.8 $2.35 Million - $3.23 Million	98,573 Added 1.09%	9,109,268 $251 Million
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $20.3 Million - $28.4 Million	877,905 Added 10.79%	9,010,695 $275 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $2.46 Million - $3.56 Million	77,827 Added 0.97%	8,132,790 $257 Million
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $24.4 Million - $32.5 Million	706,344 Added 9.61%	8,054,963 $328 Million
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $3.11 Million - $4.18 Million	93,373 Added 1.29%	7,348,619 $274 Million

Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $37.4 Million - $70.7 Million	1,127,106 Added 18.39%	7,255,246 $253 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $13 Million - $17.3 Million	240,741 Added 4.09%	6,128,140 $343 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $11 Million - $21.8 Million	285,660 Added 5.1%	5,887,399 $305 Million
Q1 2022 May 12, 2022	SELL	$58.27 - $118.99 $1.09 Million - $2.22 Million	-18,637 Reduced 0.33%	5,601,739 $407 Million
Q4 2021 Feb 10, 2022	BUY	$100.76 - $138.36 $9.01 Million - $12.4 Million	89,381 Added 1.62%	5,620,376 $665 Million
Q3 2021 Nov 09, 2021	BUY	$132.37 - $176.78 $74.8 Million - $100 Million	565,430 Added 11.39%	5,530,995 $742 Million
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $302 Million - $804 Million	4,965,565 New	4,965,565 $804 Million

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

89.3M

Call Options Held

686K

Put Options Held

599K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.7B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account